Home > Financial Ratios > PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
Core EBITDA Growth

    Back to All Ratios
PROCTER & GAMBLE HEALTH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

PROCTER & GAMBLE HEALTH Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Jun2024Mar2024Jun2023Jun2022
   Core EBITDA Growth(%) 2.21-6.25-6.2522.156.34

What is the latest Core EBITDA Growth ratio of PROCTER & GAMBLE HEALTH ?

The latest Core EBITDA Growth ratio of PROCTER & GAMBLE HEALTH is 2.21 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar20252.21
Jun2024-6.25
Mar2024-6.25
Jun202322.15
Jun20226.34

How is Core EBITDA Growth of PROCTER & GAMBLE HEALTH Trending?

Years Core EBITDA Growth % Change
Mar2025 2.21
Positive
Jun2024 -6.25
Negative
Mar2024 -6.25
Negative
Jun2023 22.15
249.37
Jun2022 6.34 -

Other Financial Ratios of PROCTER & GAMBLE HEALTH


Compare Core EBITDA Growth ratio of peers of PROCTER & GAMBLE HEALTH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PROCTER & GAMBLE HEALTH ₹8,206.5 Cr 2.8% 2.3% -9.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


PROCTER & GAMBLE HEALTH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PROCTER & GAMBLE HEALTH

2.8%

2.3%

-9.3%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses